Interagency Strategic Plan: Research and Development of Blood Products and Related Technologies for Trauma Care and Emergency Preparedness

Abstract

Therapies, including blood components and related products, are essential in treating patients with congenital and acquired diseases of the hematopoietic, hemostatic, and immune system; as well as patients with cancer, viral hemorrhagic diseases; or after surgery, trauma, and acute radiation sickness.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2015
Accession Number
AD1217082

Entities

People

  • Anthony E. Pusateri
  • Carmen Maher
  • Keith Hoots
  • Mary Homer

Tags

DTIC Thesaurus Topics

  • Air Force
  • Blood
  • Blood Diseases And Disorders
  • Brain Injuries
  • Coagulopathy
  • Combat Casualty Care
  • Combat Injuries
  • Cyanides
  • Health Services
  • Hospitals
  • Infectious Diseases
  • Medical Personnel
  • Public Health
  • Radiation Sickness
  • Therapy
  • Warfare
  • Wounds And Injuries

Fields of Study

  • Medicine

Readers

  • Cardiovascular Physiology
  • Defense Technology Research and Development.
  • Trauma or Military Medicine